Gilbert S. Omenn

Gil Omenn is the Harold T. Shapiro Distinguished University Professor in the Departments of Computational Medicine & Bioinformatics, Internal Medicine, Human Genetics, and Environmental Health at the University of Michigan, Ann Arbor. He served as UM Executive Vice President for Medical Affairs and Chief Executive Officer of the University of Michigan Health System. Earlier he was Dean of the School of Public Health & Community Medicine, Professor of Medicine and Environmental Health, and a Howard Hughes investigator at the University of Washington, Seattle. He served as a White House Fellow at the U.S. Atomic Energy Commission and as associate director of the White House Office of Science & Technology Policy and the Office of Management & Budget. He was the longtime leader of the Human Proteome Project of the global Human Proteome Organization (HUPO). He chaired the Presidential/Congressional Commission on Risk Assessment & Risk Management. His current research is focused on proteogenomics of cancers and effective and ethical uses of generative AI in healthcare. He has 711 publications. He is a member of the National Academy of Medicine, past president of the American Association for the Advancement of Science, board member of the Weizmann Institute of Science in Israel, on SABs at Princeton, Harvard Medical School, and the Institute for Systems Biology, and a director of several biotech companies. He was elected to the American Academy of Arts and Sciences in 2001.